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I 
INTRODUC7ION 
All i•fection of the uriaary tract is a problem we 
haTe had witk ua always, so from the earliest day• of 
empirical therapptica, up to and through. the preaent era 
ot relatiTely scientific medicine, there has been a eearek 
tor and a hope o! finding some drug which will produce 
sterilization of the uriaary traet.(l). Drugs and th.era-
PRtic measures may be attempted by oral admiaistratio•, 
iatraTenous therapy, and instillatio• into some portio• of 
the urinary traet directly - the kidney pelTis, the ureter• 
the bladder, or the urethra.(2). 
It will greatly simplify matter1 if we take the 
positio• and maintai• it by the positiTe etatemeat that 
•o one ot taese methods, aor all of th.em combined, has 10 
far satisfied the ideal in accomplishing the desired re-
sult to perfectio•. Ku.ck good eaa be aeeompliaaed it oae 
could suceeed ia tke idea tkat sterilizing the urinary 
tract ia depeadeat upon much more tltan the ehoice of any 
drug.(l). Urinary ia:f'ectioa is by no means a simple tl!liag. 
Wk.ea it is confined to the bladder and renal pelTie, it is 
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uaually a.JI. easy problem to eradieate it; but ia almoat all 
cases it ia not contiaed to these structures aloae.(3). 
That a giTen ease of "u:ninTeatigated" pyuria or bacteri-
uria 1laould eitller improTe or fail to improTe, !ollowiag 
the admiaistratioa of a giTea drug, ia not eTidenee ot 
particular Talue tor or aginat tke efficiency of taat 
drug. Numeroue •o-called aeceaaory, or predisposing causes 
of urinary infection must f'irst be elimiaated. Tllere are 
certaia well.-de!ined and well-reeognized, "iatra-urinary", 
predisposiag factors, whicla may be grouped uader tlle main 
lleadiaga; retentio•, calculus, new growth, and tubereul-
osia. The folly of attemptiag a cure by drug therapy of 
a urinary infection wkieh ia primarily depeadent upon on• 
of the aboTe-named meehaaical factors, is quite apparent. 
Conceraing the systemic or "extra-urinary" predisposing 
causes of urinary infection, our knowledge is relatiTely 
sea.mt and uasatisfactory. There are those cases of pyuria 
or bacteriuria occuring during the course of an aeute 
iatectious disease, and there ia tllat large group of eases 
i• which it is coasidered that ekronie focal local infect-
io• plays a role. Wh.eth.er our prediapoai•c causes ot in-
fection be intra-urinary or systemic, rendering the uriae 
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antiseptic is obTiously ridiculous. Taeretore, if accurate 
information is to be obtained, the essential preliminaries 
ia selecting eases suitable tor internal urinary tkerapy, 
are, l)a complete general pk.yaical examination, and 2) a 
complete urological examinatioa. It sllould be further noted 
taat faTorable results can not be expected in far adTanced 
cases, as, for example, bilateral pyelo:nepkritis of lo•g 
duration, with extensiTe destruction of renal tissue and 
lowering of renal :fu:nction.(4). Some ot the articles pub-
lished on the subject of urinary antiseptics in the past 
few years haTe been misleading in that they k.aTe failed to 
empkasize these facts that the urinary infection is practic-
ally always deTeloped as a result o! changes in the urinary 
tract from infections elsewhere whick. first must be treated 
to obtain a cure.(5). 
Among the Tarious opportunities for urological inTes-
tigatioa, there ia ao subject more far•reacking in its 
importance, ud more unlimited in its scope, tlLu ta.at of 
urinary antiaepsis.(6). It present• a large field tor 
medical experimentatioa. The searelL tor specific druge coea 
on witllout iaterruption aad althouglL tlle problem ll.ae re-
ceiTed no small measure of attentioa from the research in-
Teetigatiore ia the past tew years, the literature reTeals 
a aurprsinc absence of sound experimental and cliaieal 
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eTidence to the f'ittness of uy knoWJl drug to approacl& the 
desired result.(7)(4). Milch of' the adTertising done by the 
manufacturers or urinary antiseptics makes olaims £or them 
whick Tery few urologists are willing to support. An aston-
ishing thing about it has been tlu.t such adTertiainc has 
been printed in the Tery beat American journals. (5). 
Probably the most importu.t branell of tke subject of' 
urinary antisepsis, and one ot the greatest importance as 
far as the future is eoaeern.ed, is what may be termed uro-
logical bacteriology, including the cultural identitieation 
and classiticatioa of the bacterial flora found in the 
urinary tract.(6). A long list of organisms haTe been re-
ported for urinary infections, but it is full of duplic-
ations under different na:mea. RelatiTely tew organisms are 
are common inTaders, and the relatiTe frequency of til.eir 
occurrence in different parts of the tract ia taitly uni-
form. The colon bacillus is found in from 70 to 80% ot 
renal infections. Staphylococcus albus ia tke nexi most 
comma iaTader, being present ia about 10% ot thecasea. 
Then. eomea the streptococcus and the proteus TUlcaris in. 
about equal frequency, followed by scattered reports ot 
tae conocoocus and the typaoid bacillus. The findincs tor 
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the bladder are not so uniform and a much creater Tariety 
of organisms haTe been reported. The tubercle bacillus is 
probably present in about 5% of all cases.(8). It has been 
found that staphylococcus growth is aided by alkalinity 
and delayed by acidity. The reTerse ia true of Bacillua 
coli, for its growth in both acid and alkaline urine is 
luxuriant.(9}. It is a primary thought that stagnant, or 
residual, urines, at body temperature, are excellent 
culture media for many organisms, particularly the colon 
bacillus, whereas free flowing urine doea not become easily 
contaminated, but commonly carries tremendous loads of 
bacteria beyond the body without infecting it. Well known 
as is this statement, its truth is not generally appreci-
ated nor giTen the praetical consideration ita importance 
deserTes.(l). Experiments show how hard it is to infect 
the normal urinary tract, and how easy it is to infeet the 
diseased or changed tract.(5}. It has also been saoWll that 
a Tery dilute urine materially interferes with the effect-
iTeness of a urinary antiseptic because it dilutes the 
antiseptic too greatly and beeauee it increaaee the surface 
tension of the uriae making the penetratioa ot a cell 
membrane of the organism more difficult. Of course a concen-
-5-
--- -,.....--
1 
URINARY .. .A:UTI SEPSIS 
trated urine is in itself some what irritatin1 to tae 
urinary traet.(5)(10). It is a well known fact that anti-
sepsis in urine ia quite a different thing from antisepsis 
in water. There are numerous compounds which are germicidal 
in high dilutions in water, but which lose this property 
entirely when diluted in urine, eTen when in relatiTely 
high concentrations. Th.is astounding fact has proTed to 
be a great obstacle.(11). 
Urinary antiseptics could well be used in the 
following infections of the urinary tract which includes 
pyelitis of infancy, chronic pyelitis of adults, acute 
pyelonephritis, and in the acute and chronic cases of 
cystitis. It should also be of Talue as a propholactic 
following urethral instrumentation.(4)(12). Cases ot 
urinary infection, ckaracterized chlefly by frequent and 
Jainful urination, and by tke presence of pus or bacteria, 
or both, in the freshly Toided urine, are obserTed Tery 
frequently, in either sex, at any age.(13). 
The purpose of a urinary antiseptic is to ooatrol 
urinary infections and preTent th.eir exacerbations while, 
and until, the causes for tke production and continuation 
of the urinary infection are re.moTed.(14). In tke selection 
of an antiseptic, there are many desiderata whick should be 
-6-
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considered. DaTis (13) states the ideal urinary antiseptic 
should be chemically stable, eomparatiTely non-toxie, and 
noa-irritatin~ to the lower urinary tract, which is elimin-
ated, unchanged, by the kidney, and which exerts a definite 
antiseptic action in high dilution in urine ot any reaction. 
Henline and Leonard add to the definition, "and at a rate 
by which continuous antiseptic action may be attained.(15~. 
Th.e obje•t of this paper is to discuss only a tew ot 
the many preparations classified as germicides and anti-
septics useful in treatini diseases of the urinary tract, 
and to discuss their rela.ti Te efficiencies from a labora-
tory standpoint. 
-7-
EXPERIMENTAL RESULTS 
Experiments were undertaken to determine the anti-
septic value of the present day urinary antiseptics in vitro, 
using normal huma.n urine as a culture medium. The techneque 
as described by Davis in his extensive works with urinary 
antiseptics was used.(12)(16)(17). A 1% solution of the drug 
was used in va.rying dilutions, in urine, and placed in sterile 
teat tubes. A standard loop of a diluted 24 hour broth culture 
of B. coli and Staphylococcus aureus were innoculated in the 
urine, and incubated for 24 hours. At the end of this period 
one standard loop was transferred from each tube to melted 
agar and plated. Tlle plates wese inspected after another 24 
hours incubation, and the results recorded. The develop-
ment of an infinitive number of colonies (co) proved the 
corresponding urine tube to have been suitable culture 
medium for the bacteria; while the sterile plate (0 ) in-
dicated the efficient concentration of the druc for anti-
septic action. The plates were examined under low and high 
microscopic power by Dr. Edwin Davis, Department of Urology, 
University of Nebraska Collece of Medicine. 
-8-
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Table I 
DRUG DILU'l'I OliS 
1% solution 200 500 1000 3000 5000 10,000 Control 
c s c s c s c s c s c s c s 
PYRIDIUJ[ <) 0 0 0 0 0 ? 0 co 0 dlO l,000 Do Co 
UROTROPIN 0 0 0 0 0 0 c=o 0 0. 0 mol,000 OD & 
ACRIFLAVINE 0 0 0 0 0 0 0 0 0 0 0 0 
-
OD 
C.APROKOL 
- - - - - -
0 0 00 100 CDO () co Oo 
( CllQ: infinitive o : no growth C • colon lac. S • Staph.) 
Experiments were now carried out to obserTe tAe secret-
ion of antiseptic urine by man. The antiseptics were adminis-
tered to normal man, the purpose being not to attempt clinical 
cures of existing urinaru· iiiiections, but to demonstrate 
antiseptic action in speoimMa of urine Toided. after ctruc 
administration. In each instance a specimen of urine was ob-
tained before the drug was giTen and this was used. as a con-
trol, all experiments not so controlled were discarded. 
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Specimens of urine were again collected ia sterile test tubes 
at two, four, and eight hour interTals, following drug admin-
istration. Two series of tubes were used - one for colon in-
noculation and one for staphylococcus inTestigation. Nine 
( 9 c.c. ) cubic centimeters of urine were placed in their 
respectiTe tubes and one standard loop of colon bacillus was 
innoculated into each tube. The same was done for the staph• 
ylococcus. The tubes were then incubated for 24 hours and 
plated in a.gar as described already. These organisms were used 
through out the experiments because they are the most frequent 
inTaders of the urinary tract, and because they are more or 
less resistent to antiseptics, and they are readily cultiTated. 
Probably the greatest obstacle in the field of inTestigation 
is contamination. The indiTiduals who submitted to the ex.peri· 
ments were all Junior medical students on an aTerage intake of 
water. Drugs were furnished by the Tarious manufacturers. Pre-
liminary work was carried on first in order to become accus-
tomed to the techneque, correct dosage, eto.(22). 
Pyridium was the first of the series of drugs to be 
used. The dosage in this case was 0.4 gm. { gr. VI ) in the 
form of a pill furnished by Kerck and Co. The men were in-
structed to report any aubJectiTe spaptoms they noticed. 
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Table II 
Results 
Pt. Drug Dose Sub. Symp. Cont. 2hr. 4hr. 8hr. 
Pyridium 0.4gm. cs O;S e;s cs 
I 
··-1. " " Ba cl("""° ache Do ,,, .. "" :.100• ~ :eo:.oo 4111> i ' 
Headache c::iio Oo E>o ;,·-· 00 _1olo.ieo 2. II " i 
3. " " Nausea, sweat C'O :1•<10 00 '"~ I I> • ,. I~.°' 
4. " 
II Nauseated eo 'IOOO i e., 1•t> eo .Oti Oo :10& 
I 
5. u II Oo 
. eo e>o ~ CIQ 0 °": 10 
' 
6. II " Swea tin; e>o 
. Cb Oo '00 e>o 0 eo•oo 
i 
i 
7. II lf Oo : Oo Oo Co eio 0 CO•Oo 
8. II " lalaise Do 00 00 0 C:::-0 '/- e.. bo 
9. II " 
eoo ~ Oo 00 '&oo Oo e>a Q:) 
10. " " 
Do t>o 00. 0 Co Oa c::io.Oo 
11. " " Dizziness 
C::-0 co 00. 00 OIQ ; CID ooieo 
! 
' 
" 
II Nausea Oo c:>o -Co i Clo ' 12. 00 {O'D Co ·ea 
j l I I 
Feb. 15, 1932 
Urotropin, or hexamethenamine, was next used in our 
study. The same men were used as before, with the same numbers. 
Tablets, two each of seTen and one half grains were giTen by 
mouth. The drug was furnished by Schering and Glatz. Results: 
-11-
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Table III 
Reeulta 
Pt. Drue Dose SubjectiTe Cont. 2hr. 4hr. 8hr. 
Urotropin gr. u Symptoms cs cs cs 
. 
as 
! 
l. " " I 0 0() 1000 ~· 0 oj 0 0 0 i 
2. ti II Fullness Do e\) 00 0 Ol , 0 o, a 
Bladder l i 
3. II ti Co eoo ~ 10 01 0 t:lO. 0 I 
t 
' 4. " II OQ 00 Oo Oo c:>o10o ~ 
(5i<) e> 
: 
II 
" 
Oo . 00 l 5. 00 0 00~ 1' Ot:7 to•' t 
6. " II Do Oo eo '?)(> 00 ~coo Clo 0 l i 1 
7. " II 00 00 00 0 ol 0 c e ! 
a. II It Nausea cio Oo cio. 0 OCI {) 0 0 
: 
9. II 
" 
Oo Oo co eo 00 0 co .0 
10. ti " O<J : 00 0 C> 0 c 0 0 
11. II " ~ ts() 0 0 0 0 0 0 
12. If " 
.i 
Oo i C>() 0 I 0 D ~ 00 0 
' 
Feb. 20, 1932 
Caprokol, or hexylresorcinol, furnished by Sharp and 
Dome and Co., were now taken. This was giTen in gelatin cap-
sules containing o.15 gm. of the drug in 25% oliTe oil. FiTe 
of them were giTen,~with the warning to limit their intake 
of water during the day. The results were as follows: 
-12-
URINA.~Y ANTISEPSIS 
Tab:t,e IV 
Results 
. 
Pt. Drug Dose SubjectiTe Cont. 2 hr. 4 hr. 8 hr. 
-"~·. ...... _,, qs Caprokol • 75 gm. Symptoms qs qs as 
! 
' 
" " 
Pain in 00 Oo c90 :0o 0: c::oo Qa 'Co l. Abdom. 
2. It " Cramps in Co Oo cDo I~ 00 0 tso ei:, Abdom. 
" 
Oo Co 00 eo ei() I() Oo eo 3. II 
II Oto So 4. " 
IOOtJ; ~ 0 ~ Oo Co 
II 
" 
Pain in Oo Jooo Oo Co cE:'O 0 Oo ~ 5. Abdom. 
IC'o Ca /dOO 00 0 i "° eio 00 6. II fl 
' 6o C'b Oo 00 eo 10; 0 ! ~ 7. " " 
' 
1000 co 
'°° 
;00 Oo co co : Co 8. If " 
co Oo 00 00 0 O<> 'Coo ; 00 9. " " 
10. " " Co co~ 00 eo 'oo Oo O<> 
" 
n ,. 
/t>OO 0o Oo 0 000 co 11. Cramps in 00 oO 
Oo loo ~ )oo 12. II II Abdom. eo ieo t:>o Oo 
Feb. 24, 1932 
AcriflaTine giTen in 0.2 gm. doses in capsules was the 
next drug to be use4. We had the men on the day before taking 
the drug, take 4 gms. of sod. bicarbonate eTery four hours for 
three doses, in order to be sure that the urine was alkaline 
on the day of the drug administration. The following results: 
-13-
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Table V 
Results 
Pt. Drue Dose SubjectiTe Cont. 2hr. 4hr. 8hr. 
AcriflaTine 0.2 gm. Symptoms c~ as ds CjS 
! i l 0oi Oo i l. " " Oo bo ! i I o:o o:oo 
' 
! i 
2. " 
tt 001 Co I 1oool o 00 ~ 1000.l) 
i 
c.Q lo0 l 3. 
" 
tt Oo/cso O• 0 1000! 10 
! I I 
4. " " 
ooleo ~ !fJO o!"-> 001 0 ! I ! ! I 
00100 00 !Q) oio co I co 
" " 
j I 5. i ! I I 
' ! i , I 
6. II II Diarrhoea oai~ Oo !10 0 0 1ot10 lrcoc ! j 
' 
i' ' 
i 
~iQ i 7. It tt Diarrhoea 00 ! d>O 00 ~000 Co !'Q) I 
' { i 
' ~00 j 8. " " co eo co o:o 1000 i100( ! I 
9. " " C!t<) i 00 lt>OO ~ t!> iD 1000) 0 
I I I 
10. " " Diakrhoea 
i I OO'DO e::>o ~ D' 1> 0 11000 i I I 11. If 
" 
Dirrhoea Oo 'Do 00 IA O;O lloooj OQ i 
' 
12. " " 000- et> IQ) olo oJo 
llaroh 2, 1932 
The drug used in the above experiment was a trench preparation 
furnished by Poulenc Freres, Paris. This was the drug used 
by Davis in his earlier experiments. 
The next step was to compare the above brand of the 
-14-
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acriflavine with the American products. Abbott's neutral 
acriflavine in the form of a pill - gr. 1/2 - were given to 
the twelve men for the total dose of gr. VI (0.2 gm.). The 
following re~ts were obtained: 
Table VI 
Results 
Pt. Drug Dose SubJective Cont. 2hr. 4hr. 8hr. 
Acri::flavine 0.2 gm. Symptoms C;S OS C:S qs i I 
i . . 
1. It II oo; c:sio 10100 o loo co Oo 
i 
2. " " 
Ooi 00 ~ 00 OCI foo C>o i Oo 
! 
' 
i 
3. " " Headacke 
eo 00 
"° 
CIO *"' !00 00 00 I 
I 
t 
4. II " 00~00 
Qo Clo 6o loo Oo Q) 
' 
) 
! \ 
5. " 
It etoi 00 00 00 Oo iOo O(I ecs 
I 
~ ! 
" " 
Headache <>c'. Oo : 6. ~ Oo Oo !-eo co 00 ! I i 
7. " 
II 0o;oo Oo Oo do l oO 00 00 ! ( i 
. 
' 
It 
" 
Oo! &o 
°" 
00 00 l°" 00 cw a. l ' 
Oo)eo I 9. It " 
00 60 00 100 00 00 
i I 
i !eo 10. " " oo! "° DJ) 00 ~ Q, Oo ! I 
f ! 
11. " " ool dd 00 °" 00 !do PO dP I i 
12. II " Nausea dlOI *' 16o 6d Cl:1 00 CSo Qo 
March 9, 1932 
-15-
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The startling results we obtained at this point, that is the 
difference between capsule and pill administration in the same 
dosage with supposedly the same drug, led us to investigate 
further in this.respect. Abbott's powdered aeriflavine were made 
up into capsules of o.2 gm. and administered. The results: 
Table VII 
Results 
Pt. Drug Dose SubjectiTe Cont. 2hr. 4hr. 8hr. 
Acrif1aTine 0.2 gm. Symptoms cs qs cs qs i I r ; / 5 \ oj l. " " Oo;Cb oc !Co 0 io 0 i e i ! i I 
2. " " Diarrhoea ~ oO oo !ceo 010 o/ 0 i , 
: ! ! 
3. " " Headache 00 co CS1tt loo 00\00 cv!oo 
' ~ i ~ 
4. II II leo ~ ~ Nausea 
- Oo 00 0 lo 0 0 0() ' i dizziness ! : 
:a.ol I 5. n " 6o co 0 0 10 o' 0 
" 
: 
6. II " 6o 
\ 
eo 00 joCJ 0 (/00 00; 0 I 
l . ' 7. " " Diarrhoea 100• eo 0 
1 
lO 0 
l 
0 ~ol 0 
8. " 
II Nausea I co Oo ~ 1100 0:0 0 0 ; 
9. II fl 
·O· i · ' Nausea - oO 00 0 lo 00 0 
10. " 
II 
Tomi ting i 
Nausea I Oo co Co () c !ro ~ 0 
11. " II Nausea olo l - Oc> 00 010 Del 10 
Tomi ting o]o I l2a II " 10 L.~ C)O, 0 e,.... co Karch 16, 1932 
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Figure 1 
Demonstration by means of micro-photograJ.>hy an Il-;Fllfl7IVE (o:>) 
plate, 
-1?-
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Tue above illustrates a STERILE plate ( o ), or in 
other words an inhibition of the growth of the organisms . 
- 1 ?a-
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Because of t..~e lack of time, this paper being due on 
April 15, 1932, I had to draw what conclusions I could from the 
data already obtained in our experimentation with the four drugs. 
In the experiment with the different dilutions of the 
drugs in urine (Table 1, page 9), we find that acriflaTine 
shows the antiseptic action in by far the highest dilutions of 
any of the other drugs, that is, in the 1:10,000 dilution, 
aoriflavine inhiits the growth of both organisms. ~aprokol rates 
second in this series, being inhibitory to the growth of both 
organisms in dilutions of 1:3,000, but in a 1:10,000 dilution 
and upward it shows antiseptic action against the sta~hylooocci 
only. Both pyridium and urotropin in dilutions of l:l,000 show 
inhibitory action against both organisms, but in addition, in 
,dilutions of 1:5,000 staphylococci are inhibited, the colon 
) 
bacillus growing luxuriantly. 
In the experiments carried on with the twelTe individ-
uals taking the different drugs orally, we find acriflaTine 
again leading the field by a wide margin, that is, when giTen 
in the form of a capsule; in the pill form, the action is nil 
on both the colon bacillus and stavhylococcus. Whether this 
be due to the salol coating of the pill preventing absorption 
in the G.I. tract, or due to a delayed time action of the drug 
-18-
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in exerting its antiseptic action in the urine, has not as yet 
been determined, but a factor we are now working on and one 
which we hope to solve in the very near future. Acriflavine in 
either the neutral form of Abbott (Table VII, page 16) or the 
original~'Jrench product of Poulenc Freres (Table v, page 14) 
when given in capsules show a very definite antiseptic action 
in the four hour specimen of alkaline urine secreted by normal 
individuals after a single dose of the drug administered orally. 
The former seems to be a bit more effective in the two hour 
sample and it also carries over better in the eight hour sample 
than the French drug. We found two disadvantages in giving the 
drug, namely, l) the necessity of giving an alkali in oollabor-
"-
ation with the urinary antiseptic, and 2) the symptoms of nausea 
and catharsis presented by the men. VJhether these symptoms were 
due to the drug itself or to the alkali is not clear, but Davis 
is prone to believe that it is due to the drug. 
Urotropin ranks next in our aeries (Table III, page 12) 
exhibiting complete inhibition of both organisms in the four 
hour sample of urine in ? of the 12 men. Of the remaining five, 
four inhibited the staphylococci although the colon bacillus 
growth was not impaired. The antiseptic action was well carried 
over the eight hour specimens with five of the men showing a 
-19-
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complete inhibition of both organisms even as rapidly as in the 
two hour specimen. The subjective symptoms presented were few, 
the drug was easily taken and the cost comparatively small. 
Caprokol (Table IV, page 13) ran a poor third in the 
series, but it did exhibit the two facts that Leonard brought 
out in his experiments with the dnttg, namely, that the drug 
has a peculiar experimental affinity for the colon bacillus, 
even more so than the less resistent staphylococcus, but that 
the latter is destroyed in fa,r higher dilutions in the urine 
than i~ required to kill B. coli (Table I, page 9). The four 
hour sample showed only Tery weak, irregular antiseptic action 
of thedrug which was completely lost in the eight hour sample. 
Four of the twelve men complained of cramping pains in the 
lower abdomen. The drug is very expensive, and is very awi:Ward 
to give as it must be administered in large gelatine capsules 
containing olive oil. 
Pyridium. (Table II, page 11) ranks a Tery poor fourth 
in our series. The action on the colon bacillus was nil. The 
drug did show a weak antiseptic action on the staphylococci in 
both the two and four hour specimens of urine secreted by the 
normal men, after a single dose of the drug. This drug is also 
very expe~ive, and the subjective symptoms in most of the 
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Cases was nausea. In the future, we are going to try the pyrid-
ium powder given in the same dose as the pill to find it the 
results of this drug will be similar to the acriflaTine experi-
ment. 
DISCUSSIOll 
PYRIDIUlC:- a monohydrochoride of an azo dye of tae 
pyridine series ( phenyl-azo-alpaa-alpha-diamino pyridine 
kydrochl.oride ) and a semicolloidal condensation product 
of the beta and gamma isomers which may be presented struc-
turally as follows: 
gamma 
Pyridium is remotely related to quinine inasmuch as quinine 
also may be regarded as a deriTitiTe of piperidine and there-
fore of pyridine. It is to the semicolloidal property of 
quinine, imparte4 to it by the oxyquinoline radical, taat 
some authorities attribute its peculiar therapeutic power. 
Thus, similarly, pyridium's property in this instanee may 
be assigned to the phenylazo radical. Pyridine itself and 
its analogues are too toxic for use therapeutically, but 
with the addition of the radical present in pyridium., which 
impart to it its colloidal properties, not only are the 
bactericidal properties increased, but its toxicity ia low-
ered.(18)(19)(20). 
Pyridium. is a fine, microcrystalline powder, of bright 
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red color, slowly soluble in cold water, but soluble in 
boiling water, alcohol, glycerin, petrolatum, and lanolin. 
it may be administered orally ( tablet ), or applied local-
ly ( solution, powder, ointment ). It is generally usecl in 
the tablet form, each tablet containing O.l gm., the dosage 
", 
usually being 2 tablets after each meal. It is rapidly ab-
aobed and eliminated from the system practically unchanced 
in the urine. The urine is stained an orange-red, the color 
first appearing within an hour atter administration. Pyrid-
ium is compatible with practically all remedies except 
those which contain mercury. (7)(15)(19)(21). 
Four outstanding ckaracteristics are claimed by the 
drug, Pyridium, namely: its marked power of stimulation to 
the proliferation of epithelial cells, its powerful bacteri-
cidal action, its ability to penetrate the tissues, and its 
rapid elimination through the genito-urinary tract.(20). 
Only a Tery little work, experimentally, aas been 
done in this country with pyridium. It is one of the newest 
urinary antiseptics, and has just recently been accepted 
by the Council of Pharmacy and Ch.emistry. Walther in his 
work with the drug found that with the aTerage dose per day 
(0.6 gm.) and presuming that the patient excreets 3000 c.c. 
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of urine eaeh day, the pJridium was excreted almost in toto 
by the urinary tract, but that this wo~ld giTe a concentra-
tion of approximately 1:4,500, which he found was too dilute 
for effl'eient action. Therefore, he asked the patient to 
limit his fluid intake to 1500 c.e. per twenty tour hours, 
which would giTe a concentration of 1:2,000, which he says 
is within the maximum iherapeutic range of the drug. Thomas 
and Wang agree with Walther that in concentrations of l:l,000 
staphylococcus will be killed in Titro. (20)(23). This does 
not correspond to our results, howeTer, as we found that 
the staphylococcus was killed in dilutions as higk as 1:5,000. 
(see Table I). Further, we do not agree with them in that 
they they found that the colon bacillus was killed in as 
~ow a dilution as 1:400, whereas in our series there was no 
colon growth in dilutions around 1:3,000, which tends to 
support the manufactureres claims that the drug is antiseptic 
in high dilutions. 
Clinically, the drug has fared better. The seminal 
and prostatic fluids are definitely stained by pyridium 
soon after medication is instituted, and spermatozoa often 
show the presence of the dye, which also tends to proTe a 
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penetrating power of iDUmnse Talue in combating infections of 
these structures.(18). Purge, (19), has concluded that the 
drug possesses the greatest power of penetration than any 
other substance heretofor used. According to Wolbast,(21), 
pyridiwn as a general urinary antiseptic proTed to be decid· 
edly effectiTe as an adjuvant to instrwnental measures in 
pyelitis, and other upper urinary tract infections of staphyl-
ococcus and Bacillus coli origin. He considers it a promising 
addition to our therapy, but that a further study is requir-
ed. Deakin, (24), found that the aTerage duration of a control 
group of cases of acute gonorrhoea was 109 days, while the 
aTerage duration of the group on pyridium was 71 days. Aleo, 
there was a marked decrease in the frequency with which post-
erior urethritis and prostatitis deTeloped in the pyridium 
group. Whereas Pugh, (15), claims the drug is bacterioidal 
tor all organism.a infecting the urinary tract; Thomas and 
Wang claim that in no instance is the effect of B. coli inhib-
ited. 
In closing the discussion on pyridium we might add that 
to us the drug aas the requirment of being eliminated rapidly, 
is non-irritating to the l.ower urinary tract, and ia chemical-
ly stable; but experimentally, it does not proTe to be anti-
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septic - the action on staphylococci Tery slight, and on the 
colon ~acillua, nil. This with the symptoms the men presented 
upon taking the drug, and the high cost of the drug lead us 
to look further in search of an ideal urinary antiseptic. 
UBOIRQPIW: (hexamethylentetramine) a white crystalline 
substance, readily soluble in water, tasteless, colorless, and 
is made by the interaction of ammonia and formic aldehyde. In 
aci4 solutions, it at once begins to decoDI.Pose again: 
N4( CH)2+- 6H20 ~ 4NH3 +- 6CHOH 
Its action as a urinary antiseptic depends on this liberation 
of free formaldehyde. Hexamine is non-tozic, it is rapidly 
absorbed, circulates in the blood unchanged, and begine to be 
excreted in the urine in about 20 minutes, reaching its max-
imum amount there in about 4 hours.(25). Urotropin is perhaps 
the cheapest, the most conTeniently given, and the most easily 
taken of all the so-called urinary antiseptics.{5). It should 
neTer be given except in conjunction with a definite acidif-
ying a.gent, and in the minimum of 8 ounces of water to eTery 
10 grains of the drug. It is usually supplied in 5 and 7 l/2 
grains tablets, the dosage - 5 to 15 grains two to four times 
daily. (18). 
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This drug was first prepared in 1860 by Butlerow. ':i:'he 
de9no~stration of formaldehyde as a decomposition product in 
acid urine by Nioolaier, in 1895, offered to the medical 
profession a new opportunity in the treatment of urinary 
infections; antisepsis by internal medication. Richardson 
(26) described it as possessing high urinary antiseptic value 
in the treatment of typhoid feTer. Churchman (27), in 1906, 
obserTed that the effect of hexamine as a urinary antiseptic 
is expressed in an inhibition of bacterial deTelopment rather 
than as a germicide per se.(23). 
No detailed experimental inTestigation of the drug's 
actiTity as a urinary antiseptic seems to haTe been made 
until 1912, when Burnam (28) showed that in customary dosea 
(5 to 10 grains t.i.d.) of methenamine, not more than one 
patient out of five would show any formaldehyde in the urine. 
The following year Hinman (29) undertook a thorough study 
of the factors influencing the excretion of methenamine 
and its conTeraion into formaldehyde in acid urine. Of the 
318 specimens of bladder urine examined, 64% were found to 
contain so little formaldehyde (less than 1:30,000) as to 
be deToid of antiseptic value. Of the remainder, only 17% 
showed formaldehyde in concentraions sufficient for complete 
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bacteriostasis and only 5% were germicidal. Hinman concluded 
that methenamine is of no value at the kidney leTel, because 
the urine does not remain in the renal pelvis a sufficient 
length of time to permit the conversion of the drug into form-
aldehyde, and that the same condition is obtained in the blad-
der if urination is frequent. This work has since been confirm-
ed both in this countr~ and abroad by Walker, Culver, and 
Sutton.(30). The earlier claim that Urotropin is itself a 
diuretic was entirely disproved by the work of Ruh and Hana-
lick in 1922.(31). Xoderate doses of the drug will cause hem-
aturia in a small number of individuals, the bleeding being 
due to the production of a hemorrhagic cystitis. Eloedorn and 
Houghton (32), were not able to produce it at will, and they 
believe that it occurs only in those individuals who have an 
idiosyncrasy to the drug. The intravenous use of urotropine 
does not seem to be necessary or even Justified in view of 
the rapid absorption obtained upon oral administration; how-
ever, it has been successfully used at the llayo Clinic in 76 
cases of acute and sub-acute infection.(33). 
Bacteriological experiments with the drug urotropine 
have bemi very interesting. In a series of experiments on 
rabbits with induced infection of the urinary tract, Hemholz 
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and Field (34), have come to the conclusion that hexamethen-
amin is superior to mercurochrome and hexylresorcinol as a 
urinary antiseptic in cases of infection produced by staphyl-
ococcus and colon bacillus. LeTy and Strauss (35), in their 
studies of the drug come to the conclusion the hexamethylenam-
ine per se eTen up to a 10% solution has neither bactericidal 
nor marked inhibitory properties. Since the drug is neTer pre-
sent in the urine in concentrations as great as 10%, it must 
be' concluded that when awUnhibitory or bactericidal action 
is shown in the urine it can not be due to the drug itself, 
but formaldehyde. Stockman (25), of Scotland says that hexa-
mine in a strength of 1:5,000 is not strong enough to be bact-
ericidal, but in our series of dilutions (Table I, page 9) 
in the same dilution, the staphylococcus was inhibited entire-
ly, the colon bacillus, in:f'initiTe. Thomas and Wang (23) say 
that no reliance can be placed on hexametkylenamin as a 
urinary antiseptic, sice formaldehyde itself is a weak disin-
fectant, which is only liberated in the presence of acid urine. 
Furthermore, acid urine is no criterion to inaure a high form.-
aldehyde content, as, frequently they were disappointed to 
find a very low concentration of formaldehyde in a very highly 
acid specimen or urine. 
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Clinically, the drug had wide spread popularity up 
to the time of Hinman's work, and though still -.XtensiTely 
used, the newer drugs are gradually taking its place. As stat-
ed before we arepleased with the experimental results we obtain-
ed with the drug, seven of the twelTe men showing bactericidal 
urine for both staphylococcus and colon bacillus in the four 
hour sample, the relatively few symptoms, the cheapness of the 
drug; but we know the wide epa,n be;ween experimental results 
and clinical results which we will discuss in the next part 
of this thesis, so will reserve our conclusions until the end. 
CAPROKOL: (hexylresorcinol) is a white wax-like solid, 
insoluble in water, but soluble in oliTe oil.(25). It is claim-
ed to be administerable by mouth, chemieally stable, non-toxic 
in 1heraputic dases, non-irritating to the urinary tract, bact-
ericidal in high dilutions in urine of e.ny rep.ction, and is 
secreted by the kidney unchanged in sufficient percentace to 
impart actiTe bactericidal properites to the urine.(36)(37). 
The dosage internally, from 0.15 to 0.6 gm. three times a 
day, supplied in the form of an olive oil solution in a 
gelatin capsules. Children tolerate relatiTely la.rger doses 
of the drug than adulta.(38). 
Hex)Ilresorcinol is a.n alkanized resorcinol. The 
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resorcinols were first synthesized in 1913 by Johnson and ex-
amined by Rettger, who found that, as the series of alkyl re-
sorcinols were ascended, the bactericidal properties of the 
product increased Tery rapidly. It was recently intoduced as 
a urinary antiseptic following the investigation of Leonard, 
at Johns Hopkins hospital, during the years of 1914 to 1924. 
He found that coincident with this sharp rise of bactericidal 
power, there was a sharp decrease of toxicity.(39). '.i'he hexyl 
deriTitiTe of resorcinol exhibited a phenol coefficient of 46 -
the sixth C atom straight deriTitiTe as follows: 
Res ore in 
CH2CH2cH2CH2CH2CH3 
Hexylresorcinol 
Hexylresorcinol is 46 times more potent than phenol as a germ-
icide and 150 times more powerful than resorcinol. It is be-
lieTed to be one of the most powerful organic germicides eTer 
described. Unfortunately, it is detoxicatea in the body by 
beini conjugated preTious to its excretion in the urine and 
conjugated compound is inert. A sma.11 portion ( free hexyl-
resorcinol ) of it seems usually to escape detoxication, but 
i 
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the amount is neTer more than a Tery small percentage of the 
quantity inges,:d.(25). Depending, aa it seems we mast, upon 
the elimination of unconjugated hexylresorcinol in order to 
obtain bactericidal urine, it is not surprising that some in-
diTiduals would be tound to conjugate this substance more com-
pletely than others, or eTen the same individual might vary in 
this regard from week to week.(40). 
Experimentally, according to Leonard, urine examined 
after a single dose of hexylresorcinol reTeals bactericidal 
properties in 53% of the cases the lat hour, 92% in the 3rd 
hour, and 56% in the next 18 to 24 hours after administration. 
(41). In comparaing our results after a single administration 
of the drug we find no such figures. Not one man excreted 
bactericidal urine at any time tor both the organisms. Leon-
ard makes a sweeping statement when he says he has neTer en-
countered a normal man who would not secrete bactericidal 
urine with fair regu~arity after a day or two on doses 0.6 
gm. t.i.d.(40). Tests of the bactericidal action of the 
drug in normal urine were made by innoculating the urine 
with strains of B. coli and staphylococcus, and it was 
found that the organisms were destroyed in dilutions of 
l:l0,000 and upward in both acid and alkaline urine (39). 
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This was not born out in our experiments ( Table I, page 9 ) 
as we had an abudant growth of colon bacillus at the same 
dilution, although the staphylococcus was inhibited. 
\" 
Two important facts were brought out by experiment$ 
with hexylresorcinol in normal man should be emphasized, for 
the reason that they probabl~ bear some relation to the 
clinical results to be reported. Leonard found that the drug 
would destroy staphylococcus albus in far higher dilutions 
in urine of any reaction than are required to kill B. coli; 
yet of the 251 specimens of urine that were recorded, 150 
of them were bactericidal, 137 killed the colon cacillus, 
while 53 destroyed the stahpylococcus under identical con-
ditions. On this basis, it was predicted that hex.ylresorcinol 
would proTe to be more generally efficient in B. coli infect-
ions of the urinary tract than those due to the staphylococc-
us. The reverse is true.(40). 
Clinically the use of alkaliis and diuretics are 
contraindicated. Leonard brings out the fact that it is ab-
solutely essential that the ingestion of large quantities 
of fluids and of diuretic drugs by avoided during treat-
ment with hexylresorcinol. In this instance one is dealing 
with a compound which is most active, in the concentrations 
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appearing in the urine, at the lower range of surface tension. 
Not only does dilution of the urine through the ingestion of 
large quantities of water, or diuretic drugs, result in the 
lowering of the concentration of the hexylresorcinol in the 
urine, but concentrations. of the germicide which would other 
wise be highly bactericidal are inactivated by the rise of the 
surface tension of the urine which accompanies dilution.(30). 
Henline (41) in a series of 50 cases of chronic urinary infect-
ions of durations varying from 6 months to 14 years, and which 
has resisted other treatment for periods varying from one to 
forty months, obtained complete disinfection of the urinary 
tract with hexylresorcinol in all but three cases (92%). He 
avoided diuresis. On the other hand, Helmholtz (42) in a series 
of 14 cases of chronic urinary infection of duration varying 
from 6 weeks to 14 years, observed complete disinfection of 
the urinary tract with hexylresorcinol in only one case. He 
employed active diuesis. As to the alkali question, Leonard 
and Frobisher (10) and Leonard and Wood (43) have come to 
the conclusion in "their work that hexylresorcinol in acid 
or alkaline urine is equally active; yet the diuretic proper-
ties of the therapautic dose of sodium bicarbonate may be 
sufficient to inactivate the drug in the urine. 
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The question frequently comes up as to whether or not 
hexylresorcinol therapy should be considered as contraindicated 
in nephritis. Leonard and Scott (38) say that the drug has 
been administered in full doses to a number of adults suffer-
ing from chronic nephritis, complicated by urinary infection, 
and in none of these cases has there been the slightest eTi• 
dence of harm, while in some there has been a very definite 
benefit. 
Brown (39) endorses Leonarda claims for the drug which 
he considers undoubtedly a most Taluable adjunct tot.tour pre-
sent means in the treatment of infections of the urinary 
tract, but adds that approximately 50% of the 63 patients 
of his series showed gastro-intestinal dist~rbances of vary-
ing extent. Also, that the expense of the drug is one of the 
greatest objections. Thomas and Wang (23) admit the drug is 
the most scientific urinary antiseptic as yet described, 
but that its antisepsis in the urine is not constant. The 
drug seemed to be disagreeable to most of their patients on 
account of the size and number of the capsules to be swallow-
ed, which must be considered with a patient with an unsettled 
stomach. Stockman (25) concludes that the drug reduces the 
number of organisms and relieves the symptoms pomptly enough 
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but it is not especially effectiTe in eradicating the infection. 
So we find that in the end we haTe a drug highly praised by 
Leona*d and a few others - both in the experimental and clin-
ical test, but with our results, awkwardness in giTing the 
drug, the expense of it, and the symptoms presented by the 
indiTiduals taking a single dose of it all taken together, 
we cannot support its use. 
ACriflaTine: (diamino-methyl-acridium chloride) is a 
brownish-red, odorless, granular powder. It is soluble in 
about 3 parts of water; incompletely soluble in alcohol; near-
ly soluble in ether, chloroform and' thefixed oils; the aqueous 
solution is brownish-red in color, and flouresoes on dilut-
ion. (44). Laboratories in Europe and the large clinics of that 
continent haTe extensiTely inTestigated the aniline dyes. 
Based on the fact that they stain and are highly toxic to 
pathogenic organisms but less injurious to the human cell, 
acriflaTine is a product of aniline dyes and has, the follow-
ing properties: it is not impaired by the a!dition of serum, 
it does not coagulate protein substances, and in high dilut-
ion inhibits the growth of staphylococcus and the colon 
bacillus.(45). This drug, therefore,. should theoretically 
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be of clinical Talue in the treatment of Tarious infections of 
the urinary tract. As early as 1917, DaTis's (4) attention was 
attracted to acriflavine by publications in the English liter-
ature by Browning and others ( the :Bland Sutton Institute ot 
Pathology, Middlesex Hospital, London ) who showed the anti-
septic action of this drug to be increased in the presence of 
serum. Davis obtained a small sample of the drug from Brown-
ing and was the first in this country to report on acriflaTine 
as an internal antiseptic. His results seemed encouraging.(46). 
In Kay, 1923, at the meeting of the American Urological Associ-
ation, DaTis again reported the drug's internal use. His con• 
clusions were then that its use was still in the experimental 
stage. Although there has been no quantitative estimation of the 
amount of the drug appearing in the urine, it is not in eTidence 
in any other excretion and is probably completely eliminated 
by the kidney.(12). When used as an internal urinary antiseptic, 
the drug may be given in capsules or tablet form - the dosage 
usually being 0.1 gm. t.i.d. An alkali must be giTen with the 
drug to insure the urine to be alkaline. Sodium bice.rbonate, 
'4.0 gms. t~i.d. 
Experimental work with this drug has largely been· due 
to Davie. In hie preliminary work, he reported that the drug 
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inhibited the colon bacillus and staphylococcus in as high 
a dilution as 1:100,000. The drug was then given normal men 
in capsules containg 0.2 gm. doses, together with 4 gms. of 
sodium bicarbonate every four hours. The techneque used corres-
ponds to our experiments. His conclusions at that time were 
that "acriflavine administered by mouth to normal individuals 
is secreted in the urine in sufficient concentrations to render 
the urine an unfit culture medium for the colon bacillus and 
staphylococcus, providing the reaction of the urine is alkaline. 11 
(12). Stukes (45) in 1923, supported Davis in his experimental 
findings on the drug, and added that in acid urine, the sta~h­
yloco ccus is not nearly so easily killed; whereas, the colon 
bacillus in acid urine requires an exposure to a solution not 
less than 1:5,000. Davis again ran series of experiments in 
1924 and his conclusions were again in support of his earl-
ier views; more detini te clinical test4 had';,been worked out. 
In the clinical trial of acriflavine, Davis (4) 
roughly classified the following: 1) Acute Urinary Infect-
ions, including acute cystitis and non-surgical kidney infect-
ions, with staphylococcus and the colon bacillus in the urine • 
.,ut of 18 cases, in 13 there occurred an improvement character-
ized by a drop in thetemperature, a cessation of the bladder 
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symptoms, and a disap~earance of the pus and bacteria from the 
urine coincident with the starting of the dye. In the remaining 
5 cases, there was a~parantly no effect. Two patients had recurr-
ences of symptoms three months later, but it is safe to say that 
50% of the others haTe remainded well over a period of several 
months. 2) Chronic Urinary Infections, including chronic cystit-
is and chronic pyelonephritis. The results were not as good as 
those obtained in the acute series. Out of a total of 27 cases, 
there were 11 in which the treatment produced no appreciable 
effect. The remaining 16 showed distinct improvement of the 
bladder symptoms with a macroscopic and microscopic clearing 
of the urine, together with a lessening of the number or a com-
plete disappearance of bacteria from the urine. The discour-
aging feature of the chronic series was the marked tendency 
towar recurrence of infection in the urine after discontinu-
ing the dye - 12 of the 16 recurring after the urine became 
drug free. 3) Acute Anterior Gonorrhoeal Urethritis. Acriflav-
ine administered orally is not a dependable propholactic for 
preventing the extension of the infection to the posterior 
urethra. 4) Acute Posterior Gonorrhoeal Urethritis. Acrifla.v-
ine administered orally is of benefit in this condition in 
lessening the duration and the severity of the acute symptoms. 
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The clinical experiences of Stockman (25), howeTer, haTe 
not been as encouraging. He states that though the drug has 
marked bactericidal properties in vitro, the urine did not 
prove to haTe any marked bactericidal ~roperties in eases of 
Bacillus coli ~nd mild septic infections, ~nd there took place 
merely a certain amount of inhibition of the bacterial growth. 
Gray (18), in a recent article, concludes that aoriflavine is 
not as dependable or as useful as some of the newer dye prep-
arations. The oral administration of acriflavine is not with• 
out its contra-indications. Approximately 30% of DaTis's 
patients reported slight nausea or a mild catharsis, although 
this in part may be explained on the doses of sodium bicarbonate. 
(4). It is suggested that the use of acriflavine by intraven• 
ous injection is dangerous.(47). 
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The next consideration of the subject of urinary antisepsis 
is the most difficult question; the clinical application of exper-
imental results. To attempt to prove conclusiTely the clinical 
Talue of a given "experimental" urinary antiseptic is to enter 
into a problem of far greater complexity than the original lab-
oratory inTestigation. The treatment of each case is an indiTid-
ual clinical experiment, which is necessarily lac.king the 11 control1t 
which we.are able to apply to laboratory experiments.(6). Stock-
man (25) says that only very little help in overcoming the in-
herent difficulties presented in the treatment of infections of 
the genito-urinary tract by means of medicines administered by 
mouth can be got· from the kind of information yielded by experi-
ments carried out by test tubes and bacterial cultures. The 
conditions are too widely different. 
Among the many confusing variable factors which enter 
into each clinical trial, probably the chief cause for inaccuracy 
in interpretation of results is the spontaneous or unexplained 
day to day variation which is frequently obserTed in the pus 
and the bacterial content of the urine of a given individual. 
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That urine which is cloudy and infected today may be clear and 
sparU;i_gg tomorrow, for no known reason.{6). Further, f•esh 
supplies of active living organisms are constantly contributed 
from the deeper tissues of the infected urinary passages, from 
the prostate or seminal vesicles, and thus the infection may be 
kept up and renewed indefinitely. Also, once the urine is infect-
ed, it forl'Jlll a favorable culture medium which is continually 
being reinforced by blood, pus, and general organic debris that 
is present, and these elements may in addition absorb and bind 
a considerable part of the remedy and thus diminish its effective 
action on bacteria.(25). 
Coincident with these variations in the urine, we are 
accustomed toseeing alternating periods of exacerbation and 
spontaneous improvement in the clinical symptoms. Inaccuraciea 
in the interpretation of clinical results also creep in through 
the improper selection of eases - of which we mentioned earlier 
in the report. 
In view of the numerous obstacles in the way of obtain-
ing accurate and reliable clinical data, it may, therefore, be 
stated that the clinical efficiency of a given "experimental" 
urinary antiseptic must be determined by the average opinion of 
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a number of competent, unprejudiced obserTera, each of whom has 
accurately tabulated results in a series of cases sufficiently 
large to arriTe at some conclusion. As yet, no internal urin-
ary antiseptic has stood the test. We must, therefore, further 
md>4ify our definition of the ideal urinary antiseptic. We must 
distingui•h between the "experimental" and the "clinical" inter-
nal urinary antiseptic, and add that it must be of distinct, 
proven clinical value.(6). 
Careful observation will often indicate the most effect-
ive antiseptic for the particular case, and a daily check of the 
urine will show whether it is producing the expected results 
or whether a change to another drug is indicated.(5). Urinary 
infections may be treated by diuresis, or.they may be treated 
by urinary antiseptics. All experimental eTidence avaible in-
dicates decisively that these two methods of treatment should 
never be combined.(30). Whereas we have new drugs both for 
oral and intraTenous administration, and these drugs represent 
undoubted progress and are exceedingly valuable therapeutic 
agents which will ma.lee sterilization of the urinary tract lees 
difficult than it has been in the past, eTen now such steril-
ization is not an easy or simple process.(!). 
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':he following cases merely represent the typical mani-
festatipns of urinary infection. :'hey in no way help to prove 
one drug is better than another, because the cases were not 
}roperly controlled during their stay at the hospital, or prop-
erly foll.owed after their release. As already pointed out in 
an early part of this paper, to go into such a clinical experi-
ment requires much time and leads one into a field of very com• 
plex difficulties. I have only made them a part of this work to 
point out the importance of removing any foci of infection in 
the treatment of such cases, and not to expect a drug to cure 
a pyuria simply because it is listed as an urinary antiseptic. 
CASE I: A younl woman, age 24, white, married, entered the Uni-
versity hospita~ Oct. 14, 1931, having active labor pains since 
the night before. Version was done with the deliTery of a dead 
fetus. A second degree tear of the perineum was repaired at 
the time of delivery. The patient ran a normal convalescent 
period for 13 days, but at that time developed a temperature 
of 101, headache, backache, more so on the right side. The 
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physical examination at that time was negatiTe, but the urine 
(catheterized specimen) showed a 1 plus albumin, 50 pus cells 
per high power field, with a few epithelial cells and casts. 
The blood count showed a leucocytosis of 16,650. The symptoms 
increased in seTerity for the next three days - the feTer going 
as high as 104 - and the diagnosis of "pyelitia", right side, 
was made. The ~atient was put on Urotropin gr. X and Sod. acid 
phosphate gr. XXX ~.I.D. for one week. At this time her temper-
ature was down, the symptoms relieTed, and the urine negatiTe 
with the exceptia.n of a few pus cells in a high power field. 
The patient was dismissed in a few days.(36591). 
This case of pyelitis following pregnancy demonstrates 
in all probability secondary infection from the genital tract 
coupled with a lowered resistence of the patient. Urotropin 
in this case probably did much to relieTe the woman from her 
symptoms - although we do not know whether another drug would 
not haTe done just as well in causing the improTement. 
CASE II: Kan, age 25, white, single, entered the UniTersity 
hospital, Feb. 22, 1931, complaining of a constant, sharp pain 
in the left lower abdomen and back that had started one week 
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ago, and had required several "hypos" of morphine for relief. 
The physical examination showed very badly infected tonsils 
and teeth, tender rigid lower abdomen, and hyperesthesia over 
left flank; otherwise, negative. The patient said he felt 
something "pass" in his urine the second day he was in the 
hospital, and the pain eased up. X-rays of the G.U. tract were 
negative; cystoscopic examination showed the presence of an 
acute cystitis. The diagnosis was made of "acute cystitisu, 
probably as result of the badly infected tonsils and teeth. 
The patient was placed on AcriflaTine gr. 1/2 and Sod. bicarb. 
t.i.d. and sent home.(34402). Tonsillectomy was refused. 
As long as the patient has his infected tonsils acting 
as a foci of infection, we can hope for no good from the med-
ication he is receiving. Of course, we can not forget that the 
cystitis may have been a result of a stone, and if that is the 
case the drug should promptly clear up the infection. 
CASE III: Man, age 32, white, married, entered the University 
hopital, Feb. l, 1931, complaining of frequency and burning on 
urination, and severe pain in groins; one other attack one 
month ago. The physical examination was essentially negative 
with the exception of suspicious tonsills and tenderness oTer 
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the region of the bladder. The examination of the urine showed 
the presence of a 1 plus albumin, 50-60 pus cells per high pow-
er field, and many epithelial cells. C~stoscopic examination 
revealed a definite cystitis had formed; ureteral catheteriz-
ation and pyelograms showed no renal calculi, but the urine 
showed signs of pyelitis on the left side. The diagnosis was 
made of left "pyelitis" and "acute c•stitis", and the patient 
placed on acriflavine gr. 1/2 and citrocarbonate drams l t.i.d. 
Tonsillectomy was refused and the patient was dismissed, after 
being in the hospital three days. The patient returned in 3 
weeks and his tonsils were removed. He was dismissed again with 
the same therapeutics to follow.(34164). 
This again demonstrates the importance of foci of int-
ection in dealing with this type of patients; otherwise medic-
ation is to no avail. 
~ l.Y: Van, age 42, white, married entered the University 
hospital Sept. 29, 1931, complaining of pain in the lower ab-
domi3al region, frequent, burining urination, and dull frontal 
headache. The patient gaYe a history of having typhoid fever 
and septic sore throat last May, from which time he dates the 
beginning of the present symptoms. The positive points in the 
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physical examination were a very advanced pyorrhoea of both 
upper and lower jaws, some tenderness but no rigidity in the 
abdomen, and some tenderness in the left tlank. The urine at 
this time was essentially negative except for a few pus cells 
per high power field; the blood showing a slight leucocytosie 
of 12,200. X-rays of the teeth confirmed the diagnosis of 
a destructive pyorrhoea. The diagnosis of pyelitis secondary 
to oral sepsis was made, and a complete alveolectomy performed 
two weeks after entrance. The 2atient was placed on acriflaT• 
ine gr. l 1/2 and soda bicarbonate gr. X t.i.d. Patient was 
dismissed eight days after operation feeling in fairly good 
condition, the pyelitis having been cleared up. (36184). 
The question naturally arises in this case as to whether 
or not the typhoid fever had more to do with this case than the 
condition of the mouth. The literature presents many men giving 
urotropin routinely after typhoid cases for disinfection of 
the gall bladder, genito-urinary tract, and digestive tract. 
However, teeth offered a very good source of infection for 
a pyelitis and were considered the etiological factor in thie 
case. 
£.!§! y: Woman, age 58, white, married, entered the University 
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hospital, Nov. 1, 1931, complaining of continuous pain in the 
lower abdomen, nervousness, frequent, buring urination, and 
occipital headache. Patient stated she had had these attacks 
for the last number of years, are progressive in nature, the 
last attack coming on 6 weeks ago. The physical examination was 
negative - tonsils and teeth having all been removed. ':'he blood 
was negative; the urine showing a trace of albumin, a few white 
blood cells and epithelial cells. X-rays of the G.I. tract were 
all negative. The condition was thought to be largely mental in 
nature, although there was evidence of an acute cystitis. Thie 
w~s treated with Urotropine gr. X a.nd Sod. acid phosphate gr. XV 
t.i.d., along with sedatives for her nervousness. ':he urine 
cleared up 16 days after admission, the patient improved, the 
therapy discontinued and the patient dismissed. (36806). 
An etiological factor was not established in this case, 
and return of the symptoms is quite probable. It would be inter-
esting to know the follow-up history on this case. 
~.YI: Schoolgirl, age 8, white, entered the University hosp-
ital, Oct. 20, 1931, complaining of headache, weakness, spells 
of high fever, and "anemia". Patient gives a history of being 
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in the hospital a number of times before - tonsillectomy in 
1928, acute sinus infection in 1929, pyelitis in 1930. The 
child at this time showed~any white blood cells per high power 
field with many epithelial cells. The temperatmre ranged from 
99 on entrance to 104 on the seDond day - and very irregular 
thereafter. The blood was not unusual except for a slight leu-
cocytosis of 13,300. X-rays of the sinuses showed evidence of 
old infections in both antrums;;of the kidney, •ossibly slight 
widening of the major calices, but no gross deformity. 'l'he 
diagnosis of chronic pyelitis resulting from sinusitis was made 
and the patient placed on pyridium gm. 1 t.i.d. Symptomatic 
treatment for the sinuses was adTised by the consultants. The 
patient showed only an occaisional pus cell in the urine 33 
days after entrance, or three weeks after the beginning of the 
urinary antiseptic. Patient was dismissed, but referred back 
to her original doctor for further observation. (36004). 
Pyelitis in childhood is an important disease. An 
ideal urinary antiseptic could find fertile fields for cases 
such as these. The sinuses here will no doubt cause reoccur-
ence of the pyelitis in time to come. 
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CONCLUSIONS 
Our conclusions in this work are purely ex~erimental 
and in no way evaluate the clinical results that can be obtained 
with their use in the various infections of the urinary tract. 
l) ACRIFLAVINE:exhibits very definite antiseptic action in 
alkaline urine four hours after the oral administration of the 
drug to normal individuals. The drug should be administered in 
the form of a capsule, doses 0.2 gm •• Acriflavine inhibits the 
growth of colon bacillus and staphylococcus in alkaline urine 
in di_lutions of 1:10,000 and higher. 
2) UROTROPIN:exhibits definte antiseptic action in acid urine 
for both B. coli and staphylococci growth four hours after the 
oral administration of the drug. It inhibits the growth of both 
organisms in urine in dilutions of l:l,000. 
3) CAPROKOL:shows only weak, irregular antiseptic action for 
both organisms after oral administration of the drug. The 
growth of both organisms is inhibited in dilutions in the urine 
of 1:3,000. 
4) PYRIDIUM::the antiseptic action of this drug after oral 
URINARY ANTISEPSIS 
administration is practically nil in regard to the colon 
bacillus; only weak, irregular inhibitory action is demonstrat-
ed on the staphylococcus. In dilutions of 1:1,000 in urine the 
drug inhibits the growth of both organisms. 
5) We have to make up our minds that we do not as yet possess a 
perfect urinary antiseptic. The publicity given the antiseptics 
in the past few years makes it advisable to redirect the attention 
of the profession to the need of removing the causes of urinary 
infection, as well as treating the patient with the urinary 
antiseptics. Perhaps further investigation will reveal an urin-
ary antiseptic which will either cure the disease or shorten its 
course. 
###### 
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